BackgroundLow back pain (LBP) is one of the leading causes of disability worldwide, affecting approximately 80% of people over their lifetime, with estimates projecting an increase in prevalence in coming years. In addition, LBP places substantial economic strain on individuals and healthcare systems, with an estimated annual cost of AUD $4.8 billion annually to the healthcare system alone. While visits to a general practitioner (GP) contribute to these costs, many patients receive care that is not evidence-based, such as opioids and routine imaging.Waiting rooms present an opportunity to deliver health education-based multimedia interventions to improve the uptake of evidence-based care. Multimedia interventions delivered in GP waiting rooms have improved lifestyle habits, healthcare utilisation, and patients understanding of their condition in people with asthma, at risk of sexually transmitted diseases, and depression. Clinician-targeted, multifaceted interventions for LBP in emergency departments (EDs) ha

Background Research priority-setting (RPS) processes in the Philippines have applied a combination of principles and RPS frameworks such as the James Lind Alliance framework, Philippine National Health Research System Guidelines for Health Research Prioritization, bottom-up with top-down inputs approach, multi-criteria decision analysis, nominal group technique, and consensus-building. In a 2023 case study, the gaps identified highlight the need for ethical considerations and equity in RPS in the Philippine setting. Strengthening ethical considerations in health research is necessary to prevent perpetuation of inequities in global and national health systems Aim This project aims to: Analyse ethical and equity considerations in health RPS exercises conducted by the Alliance for Improving Health Outcomes (AIHO) in the Philippines. Develop recommendations for better integration of ethics and equity in future RPS activities by AIHO and in the Philippines. Research

BackgroundAneurysmal subarachnoid haemorrhage (aSAH) is a severe and life-threatening form of stroke that affects approximately 2,000 Australians each year, with a mortality rate of around 30%. Survivors often experience long-term disability and reduced quality of life, contributing to the loss of 25,000 disability-adjusted life years annually. Despite advances in stroke care, no new treatments have emerged in the past 15 years to improve outcomes for these patients. Our research group, recognising this gap, formed a collaboration in 2017 to address the urgent need for improved clinical interventions in aSAH. Through a multicentre, binational study, we revealed that the case fatality rate of 29.2% has remained stagnant over the last decade, with patients requiring ICU admission facing a higher mortality rate and prolonged hospital stays compared to other neurological conditions.Further research into the long-term outcomes of aSAH patients identified significant functional impairment six months after their ICU

Background Ventilator-associated infections (VAI) represent a significant health burden among ICU patients, particularly those suffering from acute brain injuries. Conditions such as traumatic brain injury, subarachnoid haemorrhage, stroke, and status epilepticus often lead to reduced consciousness and impaired airway reflexes, which increase the risk of aspiration and subsequent lower respiratory tract infections, including pneumonia. These infections can exacerbate brain injury by causing hypoxia and increased intracranial pressure, both of which are linked to higher mortality rates and poor clinical outcomes. Globally, ventilator-associated pneumonia (VAP) is reported to affect between 9% and 27% of intubated patients, with particularly high mortality rates among those with neurological injuries. In this vulnerable patient group, preventing infections is critical to reducing mortality and long-term disability. However, the use of prophylactic antibiotics remains contentious due to concerns